Chemical Compound

fluprostenol

CAS Registry Number 54276-17-4

Back to search Request a Quote

Primary Record

fluprostenol

In stock: 5,236 g
Purity: 98.7 %
CAS: 54276-17-4

Compound Identifiers & Properties

CAS: 54276-17-4
PubChem CID: 5311100
SMILES: C1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)C/C=C\CCCC(=O)O)O
Canonical SMILES: O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O

Names & Synonyms

fluprostenol
travoprost acid
(+)-fluprostenol
Fluprostenolum
Fluoprostenol
travoprost free acid
Fluprostenol, (+)-
54276-17-4
[3H](+)-fluprostenol
(+/-)-Fluprostenol
AC1NSJZQ
Fluprostenol [INN:BAN]
UNII-MEH3MCE8X1
[3H]-Travoprost acid
MEH3MCE8X1
(A+/-)-Fluprostenol
[3H]-(+)-fluprostenol
Travoprost Related Compound A
ICI 81,008
Fluprostenolum [INN-Latin]
RefChem:921725
358S7VUE5N
FLUPROSTENOL [MI]
UNII-358S7VUE5N
FLUPROSTENOL [INN]
CHEBI:60782
D05TNX
D08TWE
fluprostenol monosodium salt
ICI-80008 FREE ACID
Fluprostenol Travoprost acid
EINECS 255-029-3
WWSWYXNVCBLWNZ-QIZQQNKQSA-N
C23H29F3O6
40666-16-8
ICI 80,008 FREE ACID
Travoprost related compound A A
BSPBio_001336
DTXSID7046122
SCHEMBL230607
ICI 81008
ICI-81008
BML2-G08
GTPL1940
GTPL3417
orb1306434
CHEMBL1201379
DTXCID5026122
SCHEMBL29575183
AL-5848
Travoprost related compound A [USP]
HMS1361C18
HMS1791C18
HMS1989C18
HMS3402C18
HMS3648H08
EX-A3612
FLUPROSTENOL,ETHANOL SOLUTION
ZINC4474587
Tox21_111778
1007AH
1771AH
BDBM50206025
MFCD03427566
NCGC00160386-01
Travoprost related compound A RS [USP]
AKOS024458212
C23-H29-F3-O6
AL 5848
CID5311100
DB11519
CID:5311100
IDI1_033806
NCGC00160386-02
NCGC00160386-04
NCGC00160386-05
BT176360
DA-68970
FF103958
MS-28380
SID:53786902
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
CAS-40666-16-8
HY-108560
J238.396I
CS-0029169
G90905
TRAVOPROST RELATED COMPOUND A [USP-RS]
276F174
C006326
SR-01000946504
5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-buten-1-yl)cyclopentyl)-, (5Z)-
A1032088
SR-01000946504-1
TRAVOPROST RELATED COMPOUND A [USP IMPURITY]
BRD-K31611373-001-02-7
Q27077691
(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid
B1370-447705
(5Z ,13E )-(9S,11R,15R )-9,11,15-Trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20-tetranor-5,13-prostadienoic acid
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid
16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2alpha
(+/-)-16-(3-Trifluoromethylphenoxy)tetranorprostaglandin F2alpha
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoic acid
16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2|A
fluprostenol, ((1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-))-isomer
rac-(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoic acid
16-(M-TRIFLUOROMETHYLPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.
fluprostenol, ((1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-(+-))-isomer
(+/-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-DIHYDROXY-2-((E)-(3R*)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
(5Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-(trifluoromethyl)phenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoic acid
(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl)hept-5-enoic acid
(Z)-7-[(1alpha)-3alpha,5alpha-Dihydroxy-2beta-[(3R,1E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid
(Z)-7-[(1alpha,2beta,3alpha,5alpha)-3,5-Dihydroxy-2-[(3R,1E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid
[1R-[1|A(Z),2|A(1E,3R*),3|A,5|A]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid
[1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid
255-029-3
5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTEN-1-YL)CYCLOPENTYL)-, (5Z)-REL-
5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.)-,(+/-)-
5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-, (1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.)-
5-Heptenoic acid, 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)-
5-Heptenoic acid, 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+.)-
rac-(5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid